Advertisement
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC

Less Than One in 20 Eligible Adults Receives Lung Cancer Screening

0

Lung cancer screening at the state level does not correlate with lung cancer burden

Delay in Cancer Treatment Linked to Increased Mortality

Rates of VTE, Major Bleeding High in Primary CNS Lymphoma

0

Pulmonary embolism and major bleeding linked to increased mortality risk

~65 Percent of Office-Based Doctors Can ID Patients in Need of Follow-Up

Wrong-Patient Order Entry Errors Reduced With Patient Photos

0

Display of patient photographs in electronic health records associated with decrease in WPOE errors

Lung Cancer Tied to Most Potential Years of Life Lost

Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC

0

Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib

AI Model May Predict Immunotherapy Response in Melanoma

0

Histology slides, clinical data used to predict immune checkpoint inhibitor response in advanced melanoma

Medicaid Expansion Tied to Increased Detection of Early Cancers

0

Three years after expansion, a decrease in late-stage cancers was also detectable

Triplet Therapy Slows Refractory Multiple Myeloma

0

Progression-free survival longer with once-weekly selinexor-containing regimen versus standard bortezomib and dexamethasone

Vitamin D Supplementation Tied to Reduction in Advanced Cancer

0

On stratification by BMI, significant reduction found in incident metastatic or fatal cancer in normal weight, not overweight/obese

Laparoscopic Resection May Be An Option for CRC Liver Metastases

0

For resectable colorectal liver metastases, five-year survival rates similar with laparoscopic, open surgery

Lung Cancer Tied to Most Potential Years of Life Lost

0

Potential years of life lost per death highest for deaths due to cancers of testis, bones/joints, other endocrine sites